Perioperative medicine & outcomes
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations
Authors' conclusion
Society-endorsed statements and guidelines provide varying recommendations on the perioperative management of GLP-1 RAs.
Study context
- Population
- Society-endorsed statements and guidelines on perioperative management of GLP-1 receptor agonists
- Participants
- 14 society statements
- Outcome
- Variation in society guidance
Methodological detailsinternet search of society-endorsed statements and guidelines, top 20 countries by anesthesiology society membership (World Federation of Societies of Anesthesiologists), English only
- Internet search of society-endorsed statements and guidelines
- Top 20 countries by anesthesiology society membership (World Federation of Societies of Anesthesiologists)
- English only
Main finding
As reported in the abstract
- Endorsed statements from 14 major anesthesiology, endocrinology and gastroenterology societies
- Considerable variation in recommendations: withholding before surgery and its duration, avoiding deep sedation or GA, RSI use, prolonged fasting and clear fluid before nil per os, recognition of aspiration-risk signs and symptoms, perioperative glucose management, POCUS for risk assessment
Original publication
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations. Can J Anaesth. Published 26 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →